Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Johnson & Johnson to Acquire Atraverse Medical
Financial & Business, OEM News

Johnson & Johnson to Acquire Atraverse Medical

Atraverse’s Hotwire transseptal access system is an FDA-cleared RF guidewire and generator system.

Johnson & Johnson has begun an agreement to acquire Atraverse Medical, a privately-held company pioneering next-gen left-heart access and radiofrequency (RF) technology.

Atraverse’s Hotwire transseptal access system is a U.S. Food and Drug Administration (FDA)-cleared RF guidewire and generator system used for more confidence and control when accessing the left atrium. The system features impedance-sensing automatic energy shutoff, compatibility with multiple sheaths, and clear tip visibility under intracardiac echocardiography.

Achieving safe and precise access to the left atrium remains one of the most pivotal steps in atrial fibrillation (AFib) detection.

This acquisition seeks to bolster J&J’s portfolio of cardiac ablation solutions, giving electrophysiologists tools to treat patients with AFib and other cardiac arrhythmias. The deal’s financial terms were not disclosed.

The Hotwire transseptal access system has already been used in almost 3,000 procedures. Earlier this month, Atraverse shared new clinical and preclinical data that further validate the safety, performance, and workflow advantages of its Hotwire system.

The findings demonstrated reduced unintended tissue injury, low radiofrequency (RF) duration, and consistent performance across diverse procedural workflows, reinforcing the clinical value of Hotwire’s impedance-guided technology and zero-exchange approach to left-heart access.

Earlier this week, J&J earned CE mark approval for its Ethicon 4000 stapler, an advanced surgical stapler engineered for reliable staple line integrity for a variety of tissue thicknesses.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters